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ABSTRACT
Objective: To examine the supporting evidence of advertisements published in six leading
orthodontic journals.
Materials and Methods: The 2012–2013 printed issues of American Journal of Orthodontics and
Dentofacial Orthopedics, Australian Orthodontic Journal, Journal of Orthodontics, European
Journal of Orthodontics, Journal of Clinical Orthodontics, and Journal of Orofacial Orthopedics
were screened for advertisements implying superior performance compared with competitor
products. Advertisements were classified according to type of product, availability, and currency of
supporting references.
Results: A total of 99 unique advertisements claiming clinical benefit or superiority were identified.
The overwhelming majority of the identified advertisements promoted appliance products (62.6%),
orthodontic materials (14.1%), and dental operatory equipment, including imaging systems
(12.1%). Advertisements were found to provide references or not regardless of the product type.
Half of the advertisements referred to at least one peer-reviewed publication, whereas unpublished
studies were cited by 25% of the advertisements. Most of the referenced articles were published
within the past 5 years.
Conclusions: The scientific background of advertisements in the orthodontic literature appears
limited. While surveillance of journal advertising needs to be regulated, clinicians are urged to
critically appraise the claims being made in orthodontic print advertisements by consulting the
associated existing evidence. (Angle Orthod. 2015;85:184–188.)
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INTRODUCTION
There is evidence that dental practitioners select
print journals as the second highest preferred infor-
mation source following continuing education courses
to support clinical decision making.1 Most scientific
journals regularly contain manufacturer advertise-
ments intended to inform the clinicians about new or
established products. Interestingly enough, even drug
prescriptions can be influenced by scientific journal
advertising.2
To increase credibility and acceptance by the target
audience, promotional claims may be accompanied by
references to supporting studies. Previous research
has indicated that evidence citation in medical journal
advertisements aimed to substantiate product claims
ranged from 12%–76%.2–7 Moreover, roughly 8 of 10
advertisements published in four major dental journals
did not provide adequate peer-reviewed evidence to
support the claims.8 However, referenced advertising
does not necessarily guarantee the quality of claims.2
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In view of the potential for errors in presentation and
irrelevance of advertisement references, health care
professionals should be able to appraise whether a
manufacturer’s statements are adequately demon-
strated.5 In orthodontics, the evidence supporting the
claims disseminated by journal advertisements has not
been formerly evaluated. Therefore, the objective of
this study was to determine the availability and type of
evidence in support of advertisement claims in six
leading orthodontic journals.
MATERIALS AND METHODS
Advertisements appearing between January 2012
and December 2013 in American Journal of Ortho-
dontics and Dentofacial Orthopedics (AJODO), Aus-
tralian Orthodontic Journal (AOJ ), Journal of Ortho-
dontics (JO), European Journal of Orthodontics (EJO),
Journal of Clinical Orthodontics (JCO), and Journal of
Orofacial Orthopedics (JOO) were identified for the
purposes of the study. We originally planned to
investigate the content of two more impact factor
orthodontic journals, The Angle Orthodontist and
Orthodontics & Craniofacial Research, but because
of complete lack of advertisements, both were exclud-
ed. The journals of choice were selected on the basis
of peer-review process, geographical origin, print
circulation, and pageviews figures, as these were
provided by journal Web sites. Furthermore, all
journals are endorsed by or represent official publica-
tions of national and international orthodontic socie-
ties. In total, 60 print journal issues and supplements
published within the 2-year period were scrutinized.
Advertisements implying superior product performance
on clinical practice or patient care9 were selected for
further evaluation. Details regarding the type of adver-
tised product, availability, types, and currency of
references included were recorded. Advertisement
versions promoting the same product were classified
as unique in cases in which the supporting reference
was not the same. In the presence of a supporting
citation, PubMed indexing of the reference article was
examined. Conference abstract references were re-
garded as unpublished studies.
Data Analysis
Descriptive statistics were used to illustrate the
presence and nature of evidence supplied by adver-
tisers to support performance statements. The Fisher9s
exact test of independence was performed to determine
the association between the type of product and
availability of supporting evidence. Statistical analysis
was implemented with the STATA version 13.1 software
(Stata Corporation, College Station, Tex).
RESULTS
Selected Advertisements
Initial hand searching of 26 AJODO, 4 AOJ, 12 EJO,
24 JCO, 9 JO, and 11 JOO issues yielded 907
advertisements. After exclusion of advertisements
lacking statements on product benefits and duplicates,
99 items remained (Figure 1). Of these advertisements,
Figure 1. Flowchart of the screening process.
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only 28 of 99 (28.3%) added references to strengthen
the manufacturer’s argument. Interestingly, five single
products appeared in commercials with and without
references; in three of these cases, more than one type
of supporting evidence was included such as peer-
review article, expert opinion, and so on. For the
remaining 71 advertisements, no citations were includ-
ed in support of the claims made. One of the journals
(AOJ) summarized in a special section of each issue the
newly advertised products, reproducing without en-
dorsement the manufacturers’ claims.
Product Category and Evidence Availability
The distribution of advertisements according to the
advertised product category is presented in Table 1.
Orthodontic appliances (62.6%), orthodontic materials
(14.1%), and devices including scanners, curing lights,
and radiographic equipment (12.1%) were the top
categories of advertisements claiming superiority in
terms of clinical features and patient comfort. Fisher’s
exact test showed that there was no association
between advertisements providing evidence and prod-
uct category (P 5 .39).
Type and Currency of Evidence
With regard to the type of evidence, 11 of the 28
references included at least one full-text article
publication, whereas data on file (ie, proprietary
information that companies are not obligated to report,
in-house unpublished studies, or conference ab-
stracts) were cited by 25% of the advertisements
(Table 2). Of these articles, six investigated treatment
appliance efficiency, three oral hygiene device effi-
ciency, one esthetics, and one diagnostics. An expert’s
statement regarding personal experience on product
performance was used in six commercials. Moreover,
a layperson’s opinion was added to a PubMed citation
in one of the advertisements. Two identified commer-
cials provided irrelevant article references. The adver-
tisers of three products, namely, a tooth-whitening
system, a micropulse generator, and an oral hygiene
appliance, clearly stated that their statements had not
been at that time substantiated by peer-reviewed
research. Finally, 8 of the 11 reference articles were
published within the past 5 years.
DISCUSSION
Identification and use of reliable, current scientific
evidence plays a central role in the practice of
evidence-based dentistry.1 While many clinicians
consult advertisements on the latest treatment inno-
vations, they should be aware that motives other than
providing information may hide behind manufacturers’
true intentions. After all, the primary purpose of
advertisements is to increase the sales of new
products or maintain sales of established products.10
Likewise, profit-driven marketing policies of drug and
device manufacturers promote presentation of re-
search findings through advertisements in an effort to
persuade prospective clients. Such promotional strat-
egies may add an impression of authenticity rather
than communicate the evidence behind product
claims.11 Under these circumstances, a critical attitude
toward journal advertising appears justified.
Our study demonstrates that less than one-third of
orthodontic journal commercials supplied references to
defend claims of product performance and superiority,
which matches favorably with the findings of a recent
dental study.8 No patterns in evidence availability
based on the type of promoted product were observed.
We further found that 50% of the supporting evidence
referred to peer-reviewed articles, primarily published
within the past 5 years. Similar studies in medical and
dental journals concluded that the published scientific
articles accounted for 18%–76% of supporting claims,
with the lowest incidence emerging in dental literature
advertisements.3,5,7–9 In two cases that included article
references, the study design did not concern perfor-
mance testing of the product of the advertisement
itself, and therefore, the study was considered
irrelevant. These manufacturers either implemented
as stated the methodology of the investigation of three
other intraoral scanners or used a general reference
on the influence of the slot size in biomechanics to
Table 1. Distribution of Advertisements Claiming Superior Product
Performance According to Evidence Availability and Product Type
Evidence Availability
Product Type No (n) Yes (n) Total (n) Total (%)
Appliances 44 18 62 62.6
Materials 12 2 14 14.1
Other devicea 8 4 12 12.1
Device for patient use 2 2 4 4.0
Mini-implants 3 0 3 3.1
Software 1 2 3 3.1
Mouth rinse 1 0 1 1.0
Total 71 28 99 100.0
a Scanner, dental unit, radiographic equipment, curing light,
whitening system, laser system.
Table 2. Distribution of Advertisements According to Type of
Supporting References
Type of Supporting Evidence Number of Advertisements
Article(s) 6
Unpublished study(ies) 7
Expert’s opinion 6
Combination including article(s) 5
Combination without an article 4
Total 28
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justify the design of the bracket of interest. Mislabeling
of references may also theoretically occur. Fourteen to
sixteen percent of the references cited by advertise-
ments in German and Swiss dental journals could not
be identified.12 We found that in three advertisements,
the identity of conference abstract references was not
disclosed. Inappropriate translation of study conclu-
sions to fit the advertiser’s message has been also
described. Even in the presence of the highest level of
evidence, advertisements tended to extrapolate ran-
domized clinical trial results to other patient groups,
dosages, or treatments.6
The relatively high frequency of ‘‘data-on-file’’
references may be due to the eagerness of manufac-
turing companies to advertise for new indications for
which the data have not yet been published in the
public literature.6 Nonetheless, data-on-file references
on advertisement copies should not a priori be
interpreted as access to readily available records. As
stated by the World Health Organization,13 access to
scientific data in the public domain, when requested,
should be facilitated for prescribers or other concerned
parties. In contrast, Cooper and Schriger5 received
from manufacturers only 20% of the data-on-file
references upon request. It is noteworthy that half of
the pharmaceutical companies that responded to the
authors’ requests for data on file denied handing over
in-house study data because of proprietary information
or company policy reasons.5 In addition, potential
interference of sponsorship or funding selective
outcome reporting and consequent bias should not
be neglected. Studies funded by the pharmaceutical
industry were more likely to announce favorable
outcomes for the sponsoring company than research
supported by other granting agencies.14
In 9 of 28 advertisements, a positive personal
experience statement was used solely or in combina-
tion with another type of evidence to support the
product’s superior performance. A survey among
orthodontists was cited to support the statement of
improved clinical outcomes with the use of the
innovative technology of transparent splints. Clinical
photographs obtained at the start and at the end of
treatment, occasionally with the name of the operator-
practitioner, were posted on five advertisements.
Nevertheless, in all but two advertising copies, no
patient photographs with the appliances advertised in
place were included. Images of different magnification
of vacuum-formed removable appliances were dis-
played side by side to confirm the esthetic superiority
of finishing of the advertised product. Manufacturers of
orthodontic materials further highlighted the superior
properties of an elastomeric chain compared with
competing products, as this was documented by
‘‘numerous’’ but not cited ‘‘independent clinical tests.’’
Advertisers were also keen on using phrases to stress
the evidence availability on the proven performance of
their products, even in cases of untraceable or
nonoperative link sources. Lastly, besides the tradi-
tional display of attractive models with full smiles,
cartoon figures were recruited to illustrate the product’s
effectiveness.
Medical marketing and advertising need to be
regulated to prevent misrepresentation of product
features and performance. In the past, reviewers of
pharmaceutical ads in medical periodicals encoun-
tered deficiencies even in areas in which the Food and
Drug Administration (FDA) had established explicit
quality guidelines.15 With reference to orthodontics, a
number of orthodontic appliances and attachments are
assigned to Class I devices according to FDA
classification: devices posing the lowest risk to patients
and exempt from the premarket notification proce-
dures. Manufacturers are required only to register their
establishment and list the generic category or classi-
fication name. This group of devices, coded as
872.5410, comprises preformed metal and elastic
bands, band materials, metal brackets, wire clamps,
preformed space maintainers, orthodontic expansion
screw retainers, springs, tubes, and archwires.16 It is
unfortunate that intergovernmental regulatory bodies
such as the Global Harmonization Task Force,
although being involved in all aspects that have direct
impact on the safety and performance of medical
devices, do not place advertising demands on manu-
facturing companies.
In real-life clinical practice, because of lack of time,
readers might take for granted advertisement state-
ments without looking into the reliability and accuracy
of the supporting evidence.9 High-profile periodicals
are expected to run meticulous review procedures not
only for research articles under submission but
advertisements as well. Well-defined guidelines may
address space limitations of the advertising format and
enable proper presentation of validity, significance of
results, and applicability to clinical practice.17 Lack of
publication references to prove the advertisement
claims may be partly compensated by inclusion of a
clear ‘‘not yet verified by peer-reviewed research’’
statement, as a few orthodontic manufacturers did in
this study. Despite the fact that 40% of North American
medical journal editors were in favor of subjecting
pharmaceutical advertisements to the same rigorous
peer review as scientific articles, this did not occur in
practice.18 Undoubtedly, nearly all medical journals rely
to some extent on advertising revenue to manage high
publishing costs, and absolute elimination of commer-
cials may be unrealistic, especially for small journals.
On the other hand, alternative revenue sources
may include fund-raising campaigns and donations,
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subscriptions, publication fees for accepted research
papers, and advertising of products not related directly
to clinical practice, such as management and market-
ing services.
This study presents specific shortcomings. Analysis
was limited to six journals, five published in English
and one bilingual, and examined 2 years of publication.
A more comprehensive review expanding the number
of periodicals, language, and years of publishing might
have traced different trends. Hypothetically, choosing
a longer observation period could have increased the
pool of results but not necessarily the significance of
conclusions, as advertisements of obsolete products
might have been identified. No attempt was made to
contact manufacturers to obtain full records of data-on-
file references. Yet, based on the previous unwilling-
ness of pharmaceutical companies to provide research
material referenced by advertisements,5 it is unlikely
that requests for data-on-file information would have
changed the results.
The vast majority of advertisements in the orthodon-
tic literature do not provide supporting data directly
available to readers. Clinicians should be able to
critically appraise the content of advertisements. Fur-
ther improvement of surveillance mechanisms will
ensure that journal ads provide proper product promo-
tion and consumer protection. Enhanced accessibility to
and censoring of the validity of the orthodontic journal
advertisements may reinforce evidence-based decision
making in clinical orthodontics.
CONCLUSIONS
N Evaluation of a representative sample of orthodontic
journal advertisements showed that less than one-
third of commercials provided references to support
product claims. The claims supporting evidence
included peer-reviewed publications in only half of
the advertisements with references.
N Based on the limited evidence availability in support
of advertisement statements, orthodontists should
be cautious in taking at face value manufacturers’
recommendations for clinical practice.
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